Aaron F. Barkoff submits: Generic drug makers typically set their litigation sights on brand-name drug companies. Their goal is to invalidate the brand companies' patents and earn the right to market their generic drugs before the patents expire. Increasingly, however, generics are suing each other to protect or gain market share.
Read the rest here.
No comments:
Post a Comment